Results 131 to 140 of about 25,551,850 (384)
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
A comprehensive review of the application of plasma gasification technology in circumventing the medical waste in a post-COVID-19 scenario [PDF]
Rajneesh Kaushal +2 more
openalex +1 more source
Aspera Evaluation Report [PDF]
The Technology Investigation Service's Technology Evaluation team conducted an evaluation of the Aspera file transfer tool.
The Technology Investigation Service's Technology Evaluation Team
core
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Mobile phone-based biosensing: An emerging “diagnostic and communication” technology
Daniel Quesada-González, Arben Merkoçi
openalex +2 more sources
Merits and advances of microfluidics in the pharmaceutical field: design technologies and future prospects [PDF]
Amr Maged +3 more
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source

